Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000415318

Medchemexpress LLC Levistolide A | 88182-33-6 | 380.48 | 1 ML
SDP

Catalog No. 5000415318
Encompass_Preferred

Levistolide A is an apoptosis inducer and a PEDV (porcine epidemic diarrhea virus) inhibitor. It induces apoptosis in colon cancer cells and suppresses PEDV replication by promoting ROS generation. It activates peroxisome proliferator-activated receptor γ (PPARγ) and reduces excessive phosphorylation of tau through the GSK3α/β pathway, which improves Alzheimer's symptoms in mice. Additionally, it improves kidney damage in 5/6 nephrectomy (Nx) mice by inhibiting the RAS, TGF-β1/Smad, and MAPK pathways.

  • Apoptosis inducer
  • PEDV virus inhibitor
  • Induces apoptosis in colon cancer cells
  • Suppresses replication of porcine epidemic diarrhea virus (PEDV)
  • Activates PPARγ and reduces tau hyperphosphorylation, improving Alzheimer's symptoms
  • Improves kidney damage by inhibiting RAS, TGF-β1/Smad, and MAPK pathways

Catalog No. 50-004-15318 Supplier Medchemexpress LLC Supplier No. HYN147210MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Levistolide A is an apoptosis inducer and a PEDV (porcine epidemic diarrhea virus) inhibitor. It induces apoptosis in colon cancer cells and suppresses PEDV replication by promoting ROS generation. It activates peroxisome proliferator-activated receptor γ (PPARγ) and reduces excessive phosphorylation of tau through the GSK3α/β pathway, which improves Alzheimer's symptoms in mice. Additionally, it improves kidney damage in 5/6 nephrectomy (Nx) mice by inhibiting the RAS, TGF-β1/Smad, and MAPK pathways.

  • Apoptosis inducer
  • PEDV virus inhibitor
  • Induces apoptosis in colon cancer cells
  • Suppresses replication of porcine epidemic diarrhea virus (PEDV)
  • Activates PPARγ and reduces tau hyperphosphorylation, improving Alzheimer's symptoms
  • Improves kidney damage by inhibiting RAS, TGF-β1/Smad, and MAPK pathways

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.